A de novo design probe of a dopamine receptor ligand based on a theoretical approach

被引:2
作者
Baginski, M
Claudi, F
Giorgioni, G
Fontenla, JA
Rosa, E
Cardellini, M
机构
[1] UNIV CAMERINO,DEPT CHEM SCI,I-62032 CAMERINO,ITALY
[2] GDANSK TECH UNIV,DEPT PHARMACEUT TECHNOL & BIOCHEM,PL-80952 GDANSK,POLAND
[3] UNIV SANTIAGO DE COMPOSTELA,FAC PHARM,DEPT PHARMACOL,SANTIAGO COMPOSTE 15706,SPAIN
关键词
D O I
10.1006/bioo.1996.0031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A trial to design de novo a dopamine (DA) receptor ligand was made, taking as the base four structural and electrostatic requirements: (1) a group simulating the interaction of the DA amino group with the TM3 aspartic acid of the receptor, (2) a group that can simulate the interaction of the DA m-hydroxyl group with the TM5 serine of the receptor, (3) a distance between these groups similar to that of the DA anti-coplanar conformer, and (4) a rigid structure keeping the distance between the groups right. After the design ''on paper'' of the models of four structures, quantum chemistry calculations were performed to check the properties of the molecules, and then the most encouraging ones were synthesized. None of the compounds synthesized was able to bind D-1- and D-2-dopamine receptor subtypes; this shows that the structural and electrostatic requirements considered in this work are insufficient. In particular, the presence of an arylethylamine moiety seems to be essential for the interaction of a ligand with the DA receptor. (C) 1996 Academic Press, Inc.
引用
收藏
页码:358 / 375
页数:18
相关论文
共 29 条
[1]   MOLECULAR ELECTROSTATIC POTENTIAL OF D1 AND D2 DOPAMINE AGONISTS [J].
ALKORTA, I ;
VILLAR, HO .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) :210-213
[2]  
[Anonymous], 1971, NSRDSNBS37
[3]  
AONO T, 1978, CHEM PHARM BULL, V26, P1511
[4]   SYNTHESIS AND BETA-ADRENERGIC PROPERTIES OF (E)-N-[3-(ALKYLAMINO)-2-HYDROXYPROPYLIDENE](METHYLOXY) AMINES SUBSTITUTED WITH AN AROMATIC GROUP ON THEIR [(METHYLOXY)IMINO] METHYL MOIETY (MOIMM) - AN INVESTIGATION INTO THE BIOPHARMACOLOGICAL EFFECTS OF AN ARYL SUBSTITUTION IN THE CLASS OF MOIM BETA-BLOCKING DRUGS [J].
BALSAMO, A ;
BRESCHI, MC ;
CHIELINI, G ;
FAVERO, L ;
MACCHIA, M ;
MARTINELLI, A ;
MARTINI, C ;
ROSSELLO, A ;
SCATIZZI, R .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (10) :743-755
[5]   AMINO-AROMATIC INTERACTIONS IN PROTEINS [J].
BURLEY, SK ;
PETSKO, GA .
FEBS LETTERS, 1986, 203 (02) :139-143
[6]   MOLECULAR-DYNAMICS OF DOPAMINE AT THE D2 RECEPTOR [J].
DAHL, SG ;
EDVARDSEN, O ;
SYLTE, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :8111-8115
[7]   SYNTHESIS OF 2,3-DIHYDRO-1H-PHENALENE DERIVATIVE BY THE INTRAMOLECULAR DIELS-ALDER REACTION OF BENZYNE WITH FURAN [J].
DARLINGTON, WH ;
SZMUSZKOVICZ, J .
TETRAHEDRON LETTERS, 1988, 29 (16) :1883-1886
[8]   THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[9]  
EDVARDSEN O, 1992, Molecular Neuropharmacology, V1, P165
[10]   REFINEMENT OF THE STRUCTURE OF DOPAMINE HYDROCHLORIDE [J].
GIESECKE, J .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 1980, 36 (JAN) :178-181